1976•PubMedRequires access
A Clinical Assessment of a New Steroidal Cream Fluprednylidene-21-acetate (Decoderm).
L Marquis, C K Jagavkar
Open publisher page 0 citations
Abstract
In an open clinical trial using Decoderm cream, 55 patients suffering from eczematous diseases and other corticosteroid responsive dermatoses were studied. The cream was applied twice daily for a period of 2-4 weeks. An excellent response was obtained in 16.4%, a good response in 54.5% and a moderate response in 23.6% of the cases studied. The cream was well tolerated and no undesirable side effects were in any of these cases.